Company news
Beam Therapeutics Inc. news in 2023
Beam Therapeutics Inc.'s news releases, calls and decks from 2023, newest first.
Beam Therapeutics Appoints Biotech Executive Christi Shaw to its Board of Directors
December 13, 2023
Beam Therapeutics to Participate in 2023 Jefferies London Healthcare Conference
November 7, 2023
Beam Therapeutics Reports Pipeline and Business Updates and Third Quarter 2023 Financial Results
November 7, 2023
Beam Announces Agreement for Lilly to Acquire Beam’s Opt-In Rights to Verve Therapeutics’ Base Editing Programs for Cardiovascular Disease
October 30, 2023
Beam Therapeutics Presents Preclinical Data Highlighting Utility and Durability of BEAM-301 to Correct a Glycogen Storage Disease Type I Deficiency Disease-Causing Mutation at ESGCT
October 24, 2023
Beam Therapeutics Announces Portfolio Prioritization and Strategic Restructuring Focused on Potential Near-term Value Drivers and Long-term Growth of Precision Genetic Medicines Pipeline
October 18, 2023
Beam Therapeutics Presents Preclinical Data Highlighting Utility of BEAM-302 to Correct an Alpha-1 Antitrypsin (AAT) Deficiency Disease-Causing Mutation
September 6, 2023
Beam Therapeutics Announces First Patient Dosed in Phase 1/2 Trial of BEAM-201 in Relapsed, Refractory T-ALL/T-LL
September 4, 2023
Beam Therapeutics to Participate in Upcoming September Investor Conferences
August 30, 2023
Beam Therapeutics Reports Pipeline Updates and Second Quarter 2023 Financial Results
August 7, 2023
Beam Therapeutics to Participate in Upcoming May Investor Conferences
May 16, 2023
Beam Therapeutics to Participate in RBC Capital Markets 2023 Global Healthcare Conference
May 10, 2023
Beam Therapeutics Reports Pipeline Updates and First Quarter 2023 Financial Results
May 9, 2023
Beam Therapeutics to Participate in the Guggenheim 2023 Genomic Medicines and Rare Disease Day
March 26, 2023
Beam Therapeutics Appoints Gopi Shanker, Ph.D., as Chief Scientific Officer
March 20, 2023
Beam Therapeutics to Participate in the Barclays 2023 Global Healthcare Conference
March 14, 2023
Beam Therapeutics to Participate in the 43rd Annual Cowen Healthcare Conference
February 28, 2023
Beam Therapeutics Reports Fourth Quarter and Year-End 2022 Financial Results and Reiterates Anticipated Milestones
February 27, 2023
Beam Therapeutics to Participate in the SVB Securities Virtual Global Biopharma Conference
February 6, 2023
Beam Therapeutics Reports Progress Across Base Editing Portfolio and Outlines Key Anticipated Milestones
January 8, 2023
Beam Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 2, 2023
Decks in 2023
- Investor Presentation (October 2023)
Investor deck · 26 slides · Oct 19, 2023
- Investor Presentation (January 2023)
Investor deck · 25 slides · Jan 9, 2023